ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
28 Feb 2017 17:16

Korea Stock Market Monthly Recap #11 - (February 2017)

Food for Thought - Is the major underperformance of semiconductor related stocks in Korea in February a short term blip or start of a major...

Logo
180 Views
Share
05 Feb 2017 16:08

Revisiting Samsung BioLogics at This Interesting Time

I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...

Logo
243 Views
Share
31 Jan 2017 22:29

Korea Stock Market Monthly Recap #10 - (January 2017)

The Trump economic hope continued to positively impact emerging markets, including Korea. KOSPI was up 2% in January 2017, versus our model...

Logo
318 Views
Share
30 Jan 2017 09:45

Whale Watching in the Korea Stock Market

There is an adage in the financial market that says, "Don't fight the FED." In the Korea Stock Market, there is an adage that says, "Don't fight...

Logo
245 Views
Share
bearishCelltrion Inc
20 Jan 2017 20:59

Recent Developments Not Encouraging

This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...

Share
x